Which MIGS device to use in a patient with glaucoma?
MIGS devices should be restricted to patients with mild to moderate glaucoma controlled by medication
Roibeard O’hEineachain
Published: Tuesday, February 21, 2017
In eyes where glaucoma is progressing despite maximal medication, trabeculectomy remains the best optionIn the early trials with first-generation iStents, 66% of eyes with the drainage implants compared achieved 20% IOP reduction, but also had a reduction in their requirement for IOP-lowering medications. In trials with ab interno MIGS devices which direct aqueous out to the subconjunctival space, like the XEN implant, the implants have achieved 30% to 40% IOP reductions in a high proportion of patients. The jury is still out regarding implants that direct aqueous to the suprachoroidal space. In general, MIGS devices should be restricted to patients with mild to moderate glaucoma controlled by medication. In eyes where glaucoma is progressing despite maximal medication, trabeculectomy remains the best option, he concluded.
Latest Articles
Glaucoma Treatment Under Pressure
New techniques and technologies add to surgeons’ difficult decisions
Outside the Box, Inside the Pipeline
Researchers are tackling glaucoma diagnosis and treatment from all sides.
The EHDS Is Ready for the Green Light
If proposal is approved, Europe could see better access to, and exchange and use of, health data.
ESCRS to Release Guidelines for Cataract and Refractive Surgery
Comprehensive approach to the safest and most effective modern surgery.
Barry Fellowship Opens Up ‘Whole New Field of Thought’
The 2022 recipient combines theoretical and practical to learn new treatments.
Digitalising the OR—Experience and Perspectives
Benefits include saving time and improving outcomes.
Dynamic Measures Needed for Quality of Vision
Functional visual acuity testing and straylight metering may better reflect real-world conditions.
What Is Stopping Digital OR Adoption?
Ophthalmologists know the benefits—now it’s time to construct the right plan.
Time to Move Beyond Monofocal IOLs?
European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.